ATE169676T1 - Isolierung, charakterisierung und verwendung der menschlichen beta-einheit des immunglobulin e- hochaffinitätsrezeptors - Google Patents

Isolierung, charakterisierung und verwendung der menschlichen beta-einheit des immunglobulin e- hochaffinitätsrezeptors

Info

Publication number
ATE169676T1
ATE169676T1 AT93912198T AT93912198T ATE169676T1 AT E169676 T1 ATE169676 T1 AT E169676T1 AT 93912198 T AT93912198 T AT 93912198T AT 93912198 T AT93912198 T AT 93912198T AT E169676 T1 ATE169676 T1 AT E169676T1
Authority
AT
Austria
Prior art keywords
human
immunolobulin
characterization
isolation
affinity receptor
Prior art date
Application number
AT93912198T
Other languages
English (en)
Inventor
Jean Pierre Kinet
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE169676T1 publication Critical patent/ATE169676T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT93912198T 1992-04-16 1993-04-16 Isolierung, charakterisierung und verwendung der menschlichen beta-einheit des immunglobulin e- hochaffinitätsrezeptors ATE169676T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/869,933 US5770396A (en) 1992-04-16 1992-04-16 Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E

Publications (1)

Publication Number Publication Date
ATE169676T1 true ATE169676T1 (de) 1998-08-15

Family

ID=25354480

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93912198T ATE169676T1 (de) 1992-04-16 1993-04-16 Isolierung, charakterisierung und verwendung der menschlichen beta-einheit des immunglobulin e- hochaffinitätsrezeptors

Country Status (8)

Country Link
US (3) US5770396A (de)
EP (1) EP0636177B1 (de)
JP (1) JP3534406B2 (de)
AT (1) ATE169676T1 (de)
AU (1) AU676680B2 (de)
CA (1) CA2118329C (de)
DE (1) DE69320336T2 (de)
WO (1) WO1993021317A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770396A (en) 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
IL111105A (en) * 1993-09-30 2009-05-04 Univ Pennsylvania Use of a molecule capable of inhibiting the expression of syk kinase to prepare a pharmaceutical composition for inhibiting phagocytosis
US5858981A (en) 1993-09-30 1999-01-12 University Of Pennsylvania Method of inhibiting phagocytosis
CA2184631A1 (en) * 1994-03-17 1995-09-21 John C. Cambier Product and process for regulating signal transduction pathways
GB9510718D0 (en) * 1995-05-26 1995-07-19 Sod Conseils Rech Applic Antisense oligonucleotides
US5708156A (en) * 1996-05-31 1998-01-13 Ilekis; John V. Epidermal growth factor receptor-like gene product and its uses
US5945294A (en) * 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US5871930A (en) * 1997-08-21 1999-02-16 Incyte Pharmaceuticals, Inc. High affinity immunoglobulin E receptor-like protein
US6057127A (en) * 1998-01-29 2000-05-02 Heska Corporation Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
US6299875B1 (en) * 1998-06-04 2001-10-09 Panacea Pharmaceuticals, Llc Methods to block IGE binding to cell surface receptors of mast cells
AU766882B2 (en) * 1999-02-25 2003-10-23 National Jewish Medical And Research Center Product and method for treatment of conditions associated with receptor-desensitization
EP1208194A2 (de) * 1999-08-09 2002-05-29 Genaissance Pharmaceuticals, Inc. Isogene arzneimittel-ziele: polymorphismen des gens der immunglobulin e rezeptor i alpha untereinheit
AU6904100A (en) * 1999-08-24 2001-03-19 Genaissance Pharmaceuticals, Inc. Drug target isogenes: polymorphisms in the immunoglobulin e receptor beta chain gene
EP1214429A1 (de) * 1999-09-21 2002-06-19 Isis Innovation Limited Modulierung der ige-rezeptorexpression an der zelloberfläche
AU2001234797A1 (en) * 2000-02-02 2001-08-14 Biogen, Inc. Novel high affinity immunoglobulin epsilon receptor beta-subunit-like protein and nucleic acids encoding same
US20030022250A1 (en) * 2001-05-29 2003-01-30 Dreskin Stephen C. Functional IgE test methods and compositions
US7550577B2 (en) * 2003-06-04 2009-06-23 Nihon University Regulation of expression of high-affinity immunoglobulin E (IgE) receptor β-chain
JP5131688B2 (ja) * 2005-09-20 2013-01-30 学校法人日本大学 高親和性ＩｇＥ受容体γ鎖転写調節
BR112014029417B1 (pt) * 2012-05-25 2023-03-07 Cellectis Método ex vivo para a preparação de células t para imunoterapia
MX367730B (es) * 2012-09-04 2019-09-04 Cellectis Receptor de antigeno quimerico multi-cadena y usos del mismo.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
US4620948A (en) 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4477446A (en) * 1983-07-01 1984-10-16 Usv Pharmaceutical Corporation 1-Benzazepines and their pharmaceutical uses
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
EP0286700A1 (de) * 1987-04-11 1988-10-19 Kishimoto, Tadamitsu, Prof. Biologisch aktives rekombiniertes menschliches auflösbares FcR-Fragment, dieses FcR-Fragment kodierendes Plasmid sowie dessen Herstellung
US4940782A (en) * 1987-06-08 1990-07-10 G. D. Searle & Co. Monoclonal antibodies against IgE-associated determinants, hybrid cell lines producing these antibodies, and use therefore
US4962035A (en) * 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
EP0321601A1 (de) * 1987-12-22 1989-06-28 Kishimoto, Tadamitsu, Prof. Auflösbarer rekombinierter Fc-Epsilon-Rezeptor, dessen Herstellung und Verwendung
US5091313A (en) * 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
CA2000878C (en) * 1988-10-18 1999-06-29 Jean-Pierre Kinet Cdnas coding for the subunit of the high-affinity receptor for immunoglobulin e
CA2059842A1 (en) * 1991-02-11 1992-08-12 Richard A. Chizzonite Ige-receptor-antibodies
ES2193136T3 (es) * 1991-08-14 2003-11-01 Genentech Inc Variantes de inmunoglubina para receptores especificos de fc epsilon.
US5770396A (en) 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E

Also Published As

Publication number Publication date
US6171803B1 (en) 2001-01-09
US5770396A (en) 1998-06-23
DE69320336T2 (de) 1999-04-08
EP0636177A1 (de) 1995-02-01
CA2118329C (en) 2005-11-29
DE69320336D1 (de) 1998-09-17
JPH07506486A (ja) 1995-07-20
JP3534406B2 (ja) 2004-06-07
US5807988A (en) 1998-09-15
AU4283493A (en) 1993-11-18
CA2118329A1 (en) 1993-10-28
EP0636177B1 (de) 1998-08-12
AU676680B2 (en) 1997-03-20
WO1993021317A1 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
ATE169676T1 (de) Isolierung, charakterisierung und verwendung der menschlichen beta-einheit des immunglobulin e- hochaffinitätsrezeptors
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
ATE215601T1 (de) Rezeptoren der steroid/thyroid superfamilie von rezeptoren
IL119462A (en) 1-trimethylphenyl-3-substituted 1H-pyrrol-2-amines
BG64881B2 (en) TNF-BINDING PROTEINS
DE69735942D1 (de) Neuartige inhibitoren der aktivität des wachstumsfaktors für gefäss-endothelzellen (vegf), ihre verwendungen und verfahren zu ihrer herstellung
DE3772485D1 (de) Rekombinante dns-sequenzen, diese enthaltende vektoren und verfahren zur verwendung derselben.
ATE45382T1 (de) Biosynthetisch hergestellter humannervenwachstumsfaktor, verfahren zu seiner herstellung, diesen faktor enthaltende zusammensetzungen, diesen faktor codierende dna- sequenz, vektoren, die diese sequenz enthalten und dadurch transformierte wirtszellen.
ATE166650T1 (de) Spiroazacyclischderivate als substanz p antagonisten
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
DK0559884T3 (da) Rekombinante virusvektorer til ekspression i muskelceller
DE69824597D1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
HUT75113A (en) 4-substituted piperidine derivatives useful as neurokinin antagonists
CY1109518T1 (el) Αναστολεας ενεργοποιητη αυξητικου παραγοντα ηπατοκυτταρων για χρηση σε διαμορφωση αγγειογενεσης και καρδιοαγγειωσης
DE69726884D1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
DK0851926T3 (da) Varianter af humant rekombinant gamminterferon (rhu-IFN-gamma) med forøget termisk stabilitet
DK0845943T3 (da) Nye peptider afledt fra humant heat shock protein 60 til behandling af diabetes, sammensætninger, fremgangsmåder og kits
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
YU199691A (sh) Receptor za humani interleukin-5
SE9801148D0 (sv) New receptors
ATE145426T1 (de) Für die gamma-untereinheit des rezeptors mit hoher affinität für immunglobulin e kodierende cdnas
ATE349531T1 (de) Isolierung und charakterisierung des csa-operons (etec-cs4 pili) und verfahren zu dessen anwendung
AU669149B2 (en) Expression signal-peptide-free staphylokinases
DE69322770D1 (de) Zyklische anti-tumorpromotor-verbindungen, zusammensetzungen und verfahren zur herstellung sowie ihre verwendung
DK0941341T3 (da) Nukleotidsekvens, der koder for en flavinmonooxygenase, det tilsvarende protein og deres anvendelser inden for diagnostik og terapi